Vol. 276, Issue 3, R838-R846, March 1999
A unique Na+/H+ exchanger, analogous to
NHE1, in the chicken embryonic fibroblast
Sheela G.
Bhartur1,
Leszek J.
Ballarin1,
Mark W.
Musch2,
Crescence
Bookstein2,
Eugene B.
Chang2, and
M. C.
Rao1
1 Department of Physiology and
Biophysics, University of Illinois at Chicago, 60612; and
2 Department of Medicine, The
University of Chicago, Chicago, Illinois 60637
 |
ABSTRACT |
We report the characterization of an
Na+/H+
exchanger (NHE) in embryonic fibroblasts (SL-29 cells) of the chicken,
a terrestrial vertebrate, where
Na+ conservation is important.
This exchanger is electroneutral, has a single
Na+ binding site, and is highly
sensitive to amiloride (IC50 2 µM), dimethyl amiloride (350 nM), and ethyl-isopropyl amiloride (25 nM). It is stimulated by serum, transforming growth factor-
, hypertonicity, and okadaic acid. Although these features make it
resemble mammalian NHE1, other characteristics suggest distinct differences. First, in contrast to mammalian NHE1 it is inhibited by
cAMP and shows a biphasic response to phorbol esters and a highly
variable response to increased intracellular
Ca2+ concentration.
Second, whereas full-length human and rat NHE1 cDNA probes recognize a
4.8-kb transcript in rat tissues, they recognize only a 3.9-kb
transcript in chicken tissues. An antibody against amino acids
631-746 of human NHE1 sequence fails to recognize a protein in
SL-29 cells. Rat NHE2 and NHE3 probes do not recognize any transcript
in chicken fibroblasts. The SL-29 exchanger differs markedly from the
previously characterized chicken intestinal apical exchanger in its
amiloride sensitivity and regulation by phorbol esters. These results
suggest that a modified version of mammalian NHE1 is present in chicken
tissues and imply that another functionally distinct
Na+/H+
exchanger is expressed in aves.
SL-29 fibroblasts; sodium/hydrogen exchanger isoform; aves; nonepithelial
Na+/H+
antiporter
 |
INTRODUCTION |
THE VERTEBRATE
Na+/H+
exchangers, or NHEs, are a family of transmembrane proteins that
mediate electroneutral exchange of 1 Na+:1
H+, are inhibited by the diuretic
amiloride and its analogs (8), and are important in cellular
Na+ and pH homeostasis. At least
six vertebrate exchangers have been cloned thus far: NHE1-5 from
mammalian cells (21, 22, 35),
-NHE from the trout erythrocyte (5),
and NHE6, which has been identified but not fully characterized (22).
The mammalian isoforms vary in size, tissue distribution, regulation,
membrane localization, and pharmacological characteristics. They
perform diverse roles as in the regulation of intracellular pH
(pHi), cell volume, growth, differentiation, and epithelial transport (8, 15, 16, 22, 35). However,
they all share a similar topology: the amino-terminal region with
500 amino acids is the hydrophobic transmembrane transport domain,
whereas the carboxyl-terminal region with
300 largely hydrophilic
amino acids and protein kinase consensus sequences is the cytoplasmic,
regulatory domain (21, 22, 26, 34, 35). Growth factors, hormones, and
neurotransmitters evoking tyrosine kinases, protein kinase A (PKA),
protein kinase C (PKC), or
Ca2+-CaM kinases (6, 20-22,
24, 25, 27, 30, 31, 33, 35), as well as physical factors such as cell
shrinkage, regulate exchanger activities, albeit in an isoform-specific
manner (4, 9, 10, 15). NHE1, the ubiquitous isoform, is present in almost all cell types and is located on the basolateral membrane of
polarized epithelial cells. In contrast, NHE2, NHE3, and NHE4 are
largely epithelial in distribution. Pharmacological and immunodetection studies indicate that NHE3 and NHE2 are located on the apical membrane
of epithelial cells and are involved in vectorial transport (reviewed
in Refs. 21, 22, 32, and 35).
Sodium conservation is extremely important in most terrestrial
vertebrates, and land birds such as the chicken have developed highly
efficient Na+-absorptive
mechanisms in their small and large intestines (7, 9). In a very recent
study, NHE2 and NHE3 protein and activity in chicken small intestine
and colon were reported (9). The small intestinal cells or enterocytes
have a well-developed brush-border membrane for enhanced absorption.
Na+ entry into these cells is via
a prominent apical
Na+/H+
exchanger (6, 19, 27). Previous studies in our laboratories characterized the activity and regulation of this exchanger. A prominent feature of the chicken intestinal brush-border exchanger is
that activation of any signaling pathway involving cAMP, cGMP, Ca2+, or PKC inhibits its activity
(6, 13, 20, 27, 28, 30). cAMP and cGMP appear to act via an increase in
intracellular Ca2+ (27, 28). Thus
it is very likely that the brush-border membrane exchanger(s) is
constitutively active for efficient vectorial transport and plays a
major role in Na+ conservation.
Some features of this exchanger, i.e., its sensitivity to amiloride,
inhibition by Ca2+ and PKC, and
antigenicity, resemble those of mammalian NHE3, which is the apical
exchanger involved in vectorial transport (1, 3, 6, 8, 13, 16, 27, 28,
35).
In this study we determined if the chicken also possessed a
nonepithelial
Na+/H+
antiporter, analogous to mammalian NHE1, that performed
"housekeeping" roles such as
pHi regulation, growth, and
differentiation (15, 16; reviewed in Refs. 21, 22, 32, 35).
Characterization of such an isoform would indicate any unique features
of another vertebrate nonmammalian exchanger, such as the trout
exchanger (5), and imply the importance of adaptation and divergence during the course of evolution. Chicken embryonic fibroblasts, SL-29,
were used for this purpose. They can be grown in culture and, because
they are primary cells, may likely represent the in vivo situation. We
report here a detailed characterization of the SL-29
Na+/H+
exchanger that shares some properties with mammalian NHE1 and yet is
distinct from NHE1. It is also distinct in its properties from the
chicken intestinal brush-border exchanger characterized previously (6).
Our findings suggest that avian species possess a unique family of NHE isoforms.
 |
MATERIALS AND METHODS |
Materials. Primary chicken embryonic
fibroblasts, SL-29, were obtained from the American Type Culture
Collection (Rockville, MD). Cell culture supplies were obtained from
Costar (Cambridge, MA), media and serum were from GIBCO BRL (Grand
Island, NY), enhanced chemiluminescence kit was from Amersham
(Arlington Heights, IL), 22Na was
from NEN-DuPont (Boston, MA), Budget Solve and Bio-Safe II
scintillation cocktails and vials were from Research Products International (Mt. Prospect, IL), Affi-gel 10 was from BioRad (Richmond, CA), restriction endonucleases were from GIBCO BRL and
Promega (Madison, WI), oligo(dT)-cellulose columns were from Collaborative Biomedical Products (Becton Dickinson Labware, Bedford, MA), DECAprime IITM DNA labeling
kit was from Ambion (Austin, TX), and all other chemicals and supplies
were from Sigma (St. Louis, MO) and Fisher Scientific (Itasca, IL).
Cell culture. All cells were grown in
a humidified 95% air-5% CO2
atmosphere at 37°C. The cells were subcultured using 0.1% (wt/vol)
trypsin-1 mM EDTA in PBS, pH 7.4. Chicken embryonic fibroblasts were
grown in MEM with nonessential amino acids and Earle's
balanced salt solutions, supplemented with 1 mM sodium pyruvate, 5%
tryptose phosphate broth, 5% fetal bovine serum (FBS), 10,000 U/l
penicillin, and 10 mg/l streptomycin. Because these are cells in
primary culture, they can be passaged only a few times, and different
batches needed to be procured for the complete study. Cells were
routinely received in passages
13-14, and most experiments were
performed on cells in passages
14-18. The PS127A cell line, which was developed
and kindly provided by Dr. J. Pouyssegur (26), was grown
in DMEM supplemented with 5 U/ml penicillin, 5 µg/ml streptomycin,
and 10% FBS. Tests to rule out mycoplasma contamination were not
performed, because no glaring discrepancies in cell growth pattern were noticed.
Preparation of microsomal membranes.
The cells were washed twice with PBS, scraped off, and resuspended in a
small volume of PBS. The suspension was centrifuged at 2,000 g for 15 min, and the resulting pellet
was homogenized in buffer (HB) containing (in mM) 10 HEPES-Tris, pH
7.4, 3 EGTA, 1 EDTA, 10 mannitol, 0.1 phenylmethylsulfonyl fluoride, 2 dithiothreitol (DTT), and 0.01 mg/ml
L-1-tosylamide-2-phenylethylchloromethyl
ketone, and 0.001 mg/ml each of leupeptin, pancreatic, and soybean
trypsin inhibitors. The homogenate was centrifuged at 2,000 g for 15 min, and the resulting
postnuclear supernatant was centrifuged at 100,000 g for 1 h to obtain the microsomal
membrane pellet. The pellet was resuspended in a minimal volume of HB.
Protein content was assayed by the Lowry procedure as described
previously (30).
Isolation of antibody against NHE1.
The generation and characterization of this antibody has been described
previously (18). Briefly, a fusion protein comprising the sequence of
amino acids 631-746 of human NHE1 (26) and
glutathione-S-transferase (GST) was
injected into New Zealand White rabbits (18). The polyclonal antibodies
were affinity purified using antigen linked to Affi-gel 10. To remove
antibodies to GST, the antiserum was first run on a GST column, and the
resulting flow-through was run on an NHE1 antigen affinity column. The
antibody was eluted with 0.2 M glycine-HCl, pH 2.2.
Immunoblotting. Proteins were resolved
by SDS-PAGE on 6% gels by the Laemmli method and electrotransferred to
nitrocellulose by the Towbin method using the modifications described
previously (29). The membrane was blocked in Blotto buffer containing
5% (wt/vol) fat-free dry milk powder, 150 mM NaCl, 10 mM sodium
phosphate, pH 7.4, 2 mM EDTA, and 0.2% (vol/vol) Nonidet-40 for 1 h.
It was then incubated in primary antibody (1:200) in Blotto overnight at 4°C. It was washed (2 × 5 min and 2 × 10 min in
Blotto) and incubated in horseradish peroxidase-conjugated goat
anti-rabbit IgG (1:1,000) in Blotto containing 1% nonfat milk for 1 h
at room temperature. The membranes were washed as follows: 3 × 5 min, 3 × 10 min, and 1 × 15 min in Blotto, and reaction
products were visualized by chemiluminescence.
Northern blotting. The SL-29
fibroblasts were washed in PBS and resuspended in GTC lysis buffer
containing 4 M guanidinium thiocyanate, 25 mM sodium citrate, pH 7.0, 0.5% (wt/vol) sodium lauryl sarcosinate, and 1% (vol/vol)
-mercaptoethanol. Total RNA was isolated by centrifugation in a 5.7 M CsCl cushion followed by extraction with Tris-saturated (pH 7.4)
phenol and chloroform-isoamyl alcohol (24:1) as described (23).
Polyadenylated mRNA was isolated by affinity chromatography on an
oligo(dT) cellulose column. The mRNA was separated on a 1% agarose,
6% formaldehyde gel, with RNA size markers run in parallel and
transferred by capillary action to nylon membranes (Hybond N,
Amersham). The following isoform-specific probes were used: full-length
rat heart NHE1 cDNA probe consisting of bases 614-3452, a rat
NHE2, Pst I cDNA fragment
corresponding to bases 260-3598, and a full-length rat NHE3 cDNA
consisting of bases 1-3036 (from a
PvuI
I-Nsi I fragment) (3, 15). Note that
the NHE2 probe is almost full length with 789 of the 813 translated
codons and is lacking the 3'-end noncoding sequence. The cDNA
clones were kindly provided by Dr. Gary Shull, The University of
Cincinnati, Cincinnati, OH. The vectors were incubated with the
appropriate restriction enzymes, and inserts were then purified on a
1.2% agarose gel. The purified inserts were labeled by random
oligonucleotide primers (Ambion DECAprime IITM). Hybridization and washes
are as described in the figure legend.
22Na+
uptake studies. Cells grown in 24-well clusters were
acid preloaded in a buffer containing (in mM) 50 NH4Cl, 70 choline chloride, 5 KCl,
1 MgCl2, 2 CaCl2, 5 glucose, and 15 MOPS, pH 7.0 at 37°C for 1 h. They were transferred to room temperature, and
the preload buffer was replaced by two changes of
Na+-free wash buffer (containing
120 mM choline chloride and 15 mM HEPES, pH 7.4). The cells were then
exposed to uptake buffer containing (in mM) 5 or 20 NaCl, 115 or 100 chloride, 1 ouabain, 1 MgCl2, 2 CaCl2, 20 HEPES, pH 7.4, and 1 µCi/ml of carrier-free
22Na+
for 5 min unless otherwise indicated (34). External
Na+ concentration was reduced from
20 mM in early experiments to 5 mM in later experiments to increase
22Na+
specific activity. The reaction was terminated by three washes with
ice-cold PBS. Samples were hydrolyzed in 0.1 N
HNO3 and counted by liquid
scintillation spectrometry.
Data analysis. Data are presented as
means ± SE of 3-5 experiments, unless otherwise mentioned. In
each experiment the assay was performed in triplicate. Data were
analyzed and compared using Student's
t-test for paired data.
 |
RESULTS |
Time course and kinetics of
Na+/H+
exchange. To determine whether SL-29 cells possess
Na+/H+
exchange activity and to examine the linearity of
22Na+
uptake, cells were initially acid-loaded by exposure to
NH4Cl to maximize the driving
force for the exchanger. The acid-loaded cells were exposed to uptake
buffer containing
22Na+
for 1, 3, 5, and 10 min in the presence and absence of
10
4 M of the amiloride
analog dimethylamiloride (DMA). NHE activity was calculated as the
difference between total
22Na+
uptake and uptake in the presence of DMA. As shown in Fig.
1, DMA-sensitive uptake was linear up to 10 min, whereas DMA-insensitive uptake remained relatively constant,
indicating the presence of an
Na+/H+
exchanger in the SL-29 cells. In subsequent experiments, uptake was
measured at 5 min. In the absence of an acid gradient, DMA-sensitive uptake was only 7.5-21% of that in its presence (2 experiments in
quadruplicate, data not shown). In acid-loaded cells,
22Na+
uptake was neither inhibited by furosemide nor by the stilbene derivative SITS (data not shown), suggesting that NHE was the major
Na+ transport mechanism. It must
be emphasized that SL-29 cells are primary cells, and, although we
restricted the number of times the cells were passaged, variability in
basal levels was observed from batch to batch. As it is useful for
future investigations to have such variability documented in
literature, we have expressed the data, as far as possible, in absolute
values. However when basal values varied greatly, results are expressed
as a percentage of control. Although the absolute values may differ,
the trend (stimulation or inhibition) was generally the same between
experiments.

View larger version (18K):
[in this window]
[in a new window]
|
Fig. 1.
Time course of Na+ uptake in SL-29
cells. Acid-preloaded SL-29 cells were washed twice in
Na+-free buffer and exposed to
uptake buffer containing 1 µCi/ml of
22Na+
in 20.4 mM Na+, as described in
Materials and methods.
22Na+
uptake was assayed in the absence and presence of 0.1 mM
dimethylamiloride (DMA). All buffers used were
HCO 3 free. Values are expressed as
means ± SE of triplicate measurements from 1 experiment. In all
further experiments, uptake was determined at 5 min.
|
|
Figure 2 shows exchanger activity in
response to increasing concentrations of external
Na+. After
NH4Cl-induced acidification, cells
were exposed to uptake buffer containing a concentration of
Na+
([Na+]) in the range
of 1.875 to 120 mM in the presence and absence of
10
4 M
ethylisopropylamiloride (EIPA). EIPA was used in most subsequent experiments because it was the most potent inhibitor (Fig.
3). Osmolarity was maintained constant
among the buffers by adding choline chloride. A plot of EIPA-sensitive
Na+ uptake as a function of
external [Na+] is a
rectangular hyperbola, demonstrating that the exchanger obeys
Michaelis-Menten kinetics with a single external, saturable Na+ binding site. A linear
Hanes-Woolf transformation of the data (Fig. 2, inset)
revealed a Km of 18.75 mM and a maximal velocity of 156.3 nmol · mg
protein
1 · min
1.

View larger version (14K):
[in this window]
[in a new window]
|
Fig. 2.
Effect of external Na+
concentration on exchanger activity. Effect of increasing
Na+ concentrations on the initial
rate of Na+ uptake, calculated on
the basis of the ethylisopropylamiloride (EIPA; 0.1 mM)-sensitive
component of total Na+ uptake.
Values are expressed as means ± SE of 4 experiments, each done in
triplicate. Inset: linear
transformation of the data using a Hanes-Woolf plot based on the
equation [S]/v = {[S] + Km}/Vmax,
where Km is the
Michaelis constant,
Vmax is maximal
velocity, [S] is Na concentration, and v is rate of
uptake.
|
|

View larger version (20K):
[in this window]
[in a new window]
|
Fig. 3.
Effect of amiloride and its analogs on
Na+ uptake. Inhibition profiles of
Na+ (20.4 mM) uptake into SL-29
cells exposed to varying concentrations of amiloride, EIPA, or DMA are
shown. y-Axis depicts rate of uptake
expressed as %control, i.e., in absence of inhibitor. Data are
expressed as means ± SE of 3 experiments each in the case of
amiloride and DMA and 5 experiments in the case of EIPA.
|
|
The process is electroneutral because agents known to alter membrane
potential do not affect EIPA-sensitive
22Na+
uptake in SL-29 cells. Thus addition of the
K+ ionophore valinomycin (10 µM), an agent routinely used to clamp membrane potential, had little
effect on exchanger activity (the EIPA-sensitive uptake values were
9.798 vs. 8.395 nmol · mg
protein
1 · min
1
in control and valinomycin-treated cells, respectively). Similarly, when cells were exposed to an uptake buffer containing 120 mM KCl,
there was little effect of valinomycin on EIPA-sensitive uptake.
Additionally, the electrogenic protonophore, carbonyl cyanide
m-chlorophenylhydrazone (CCCP) (10 µM) had no effect in combination with valinomycin (9.798 and 9.704 nmol · mg
protein
1 · min
1
in control and CCCP-treated cells, respectively) or by itself (9.798 and 8.028 nmol · mg
protein
1 · min
1
in control and CCCP-treated cells, respectively). These findings suggest that the
22Na+
uptake being measured occurs via an electroneutral exchanger.
Inhibition by amiloride and its
analogs. A useful way to distinguish the various
mammalian NHE isoforms is by their relative sensitivities to inhibition
by amiloride and its analogs. SL-29 cells were acidified and exposed to
increasing concentrations of amiloride and its analogs, DMA and EIPA,
in the uptake buffer containing 20.4 mM
Na+. The
IC50 values were calculated as
2 × 10
6 M for
amiloride,
3.5 × 10
7 M for DMA, and
2.5 × 10
8 M for EIPA (Fig. 3).
This potency series of EIPA > DMA > amiloride for inhibition of
exchange activity is found in a number of cell types (8, 19). Because
EIPA was the most potent analog, NHE activity was measured as the
EIPA-sensitive uptake in subsequent experiments.
An IC50 value of 1-2.5 × 10
6 M for amiloride
is shared by mammalian NHE1 and NHE2; the amiloride-insensitive NHE3
has an IC50 value one to two
orders of magnitude higher (8, 21, 32, 35). Hence the exchanger in the
SL-29 cells was likely to be related either to NHE1 or NHE2. However,
NHE2 has a lower sensitivity to EIPA than NHE1; the reported
IC50 values of NHE1 and NHE2 range from 1.5 to 2.5 × 10
8
M and 0.08 to 1 × 10
6
M, respectively (21, 35). The similarity in
IC50 values between the SL-29
exchanger and NHE1 suggests that the chicken fibroblast exchanger is an
NHE1-like molecule.
Effects of regulatory agents. Because
the pharmacological studies imply the presence of an NHE1-type activity
in SL-29 cells, we examined the effects of well-known regulators of
NHE1, such as serum, transforming growth factor (TGF)-
, okadaic
acid, and hypertonicity, on its activity. Serum stimulates NHE1
activity with a concomitant increase in NHE1 phosphorylation in
mammalian fibroblasts (24). To obviate any change in osmolality,
dialyzed FBS (10%) was used. Short-term (5 min) serum exposure caused
a 43% stimulation (Table 1). As mentioned
above, the variability in the basal levels represents batch-to-batch
differences, as these are primary cells.
The stimulation seen with serum indicates that the exchanger is
activatable by growth factors. Epidermal growth factor (EGF) and
TGF-
can be used interchangeably because they bind to the same
receptor as exemplified in chicken granulosa cells wherein EGF-induced
NHE stimulation was mimicked by TGF-
but not by TGF-
(16). In
highly confluent SL-29 cells, TGF-
(10 pg/µl or 1.67 nM) caused a
marked 230% stimulation in EIPA-sensitive
Na+ uptake (Table 1).
Mammalian NHE1 is also stimulated by pathways that involve
Ca2+ and PKC (16, 22, 34). The
effect of PKC stimulation on the SL-29 exchanger was examined by
exposing the cells to increasing concentrations of the phorbol ester,
phorbol-12,13-dibutyrate (PDB). In contrast to other NHE1 systems,
which exhibit a monophasic response, SL-29 cells exhibited a biphasic
response to PDB as shown in Fig. 4. To
determine if the SL-29 exchanger was modulated by altering
intracellular Ca2+ levels, the
cells were treated with the Ca2+
ionophore A-23187 (1 µM). A total of nine experiments, with values being determined in triplicate in each experiment, were performed. As
shown in Fig. 5, the data could be
separated into two groups. In one group comprising
n = 5, there was a 30% inhibition and in the other (n = 4), a 22%
stimulation. This variability could not be attributed to any obvious
differences in passage number, state of confluence, batch of cells, or
absolute activity values between the two groups. Because other
regulators do not have such contrasting opposite effects, it is
unlikely that a general phenomenon like clonal variability could
account for these differences. The basal activity was 10 ± 1.73 nmol/mg in group
I and 7.61 ± 1.08 nmol/mg in
group
II and therefore not statistically
different.

View larger version (16K):
[in this window]
[in a new window]
|
Fig. 4.
Effect of protein kinase C activation on
Na+ uptake. A representative curve
(of 5 experiments) is shown, where cells were exposed to concentrations
of phorbol-12,13-dibutyrate (PDB) increasing from
10 10 to
10 6 M. Data are means ± SE of triplicate measurements.
|
|

View larger version (26K):
[in this window]
[in a new window]
|
Fig. 5.
Effect of an increase in intracellular
Ca2+ concentration on
Na+ uptake. Figure depicts
Na+/H+ exchanger (NHE) activity in control or
Ca2+ ionophore (A-23187, 1 µM)-containing uptake buffer. Data divided into
group
1 (n = 5, top) and
group
2 (n = 4, bottom) on the basis of
inhibitory or stimulatory response, respectively (see
Results for discussion). Each
n value represents a separate
experiment and is average of triplicate measurements.
** Significance at P < 0.025 and
**** P < 0.0005 using paired Student's
t-tests.
|
|
cAMP generally does not affect mammalian NHE1, whereas it inhibits
mammalian NHE3 and stimulates trout
-NHE (5, 16, 33). The effect of
cAMP on the SL-29 NHE was examined by exposing cells to the cAMP
analog, chlorophenylthio-cAMP (cpt-cAMP). Addition of
10
6 and
10
4 M cpt-cAMP caused
significant decreases of
36 and 65% in activity, respectively
(n = 3). The activity with
10
4 M was significantly
less than that with 10
6 M
cpt-cAMP (Fig. 6).

View larger version (16K):
[in this window]
[in a new window]
|
Fig. 6.
Effect of cAMP on NHE activity. Graph depicts effects of
chlorophenylthio (cpt)-cAMP at
10 6 and
10 4 M
(n = 3).
y-Axis represents NHE activity as
%corresponding control, i.e., without cpt-cAMP. x, Effect at
10 4 was different than that at 10 6.
Significance of inhibition at
*** P < 0.01 and
** P < 0.025 using paired
Student's t-tests.
|
|
The pathways discussed thus far imply the involvement of kinases in the
regulation of the SL-29
Na+/H+
exchanger. To determine the role of phosphatases in this regulation, we
next examined the effects of the phosphatase inhibitors okadaic acid
and calyculin. Okadaic acid, a potent inhibitor of phosphatase IIA,
stimulates NHE1 activity in mammalian fibroblasts with a concomitant
increase in its phosphorylation (2). In highly confluent SL-29 cells, 1 µM okadaic acid caused a twofold stimulation (Table 1). In contrast,
calyculin (1 µM), which inhibits phosphatase I and IIA, had a small
but significant (12%) inhibition of
22Na+
uptake (data not shown).
Physical factors such as cell shrinkage are also known to affect NHE
activity (4, 10). On increasing the osmolarity of the medium from 270 to 400 or 550 mosM, the activity of the SL-29 exchanger increased
1.4-fold. There was no difference in the response to 400 compared
with 550 mosM (Fig. 7).

View larger version (20K):
[in this window]
[in a new window]
|
Fig. 7.
Effect of hypertonicity on Na+
uptake. Effect of hypertonicity was examined by exposing SL-29 cells to
uptake buffers of 270 (isotonic, control), 400, or 550 mosM. Osmolarity
was increased by addition of choline chloride. Activity is expressed as
%control values. * Significant increases
(P < 0.05, paired Student's t-test;
n = 6).
|
|
Molecular characterization of the
exchanger. On the basis of the functional similarities
between mammalian NHE1 and the SL-29 NHE, we attempted to identify the
SL-29 NHE using mammalian probes. SL-29 membrane proteins were probed
with a polyclonal antibody directed against a unique mammalian NHE1
sequence (amino acids 631-746 of human fibroblast NHE1) (26). This
antibody was shown previously to recognize NHE1 in nontransfected human
foreskin fibroblasts, HSWP (18), rat intestinal membranes
(3), and more recently in turtle gastrointestinal tissues (12).
Although a 105-kDa band was detected with membranes from the
NHE1-transfected fibroblasts PS127A, no product was detected in SL-29
membranes (Fig. 8) or in the NHE-deficient
PS120 cells.

View larger version (41K):
[in this window]
[in a new window]
|
Fig. 8.
Immunoblotting of SL-29 membranes with NHE1 fusion protein antibody. In
this representative immunoblot, 10 µg of PS127A and 100 µg of SL-29
membrane proteins were probed with a 1:200 dilution of NHE1 fusion
protein antibody followed by a 1:1,000 dilution of goat anti-rabbit
peroxidase-labeled secondary antibody. Reaction products (arrow) were
visualized by enhanced chemiluminescence.
Mr, relative
molecular weight.
|
|
To determine whether the SL-29 cells have a transcript related to any
of the mammalian NHE isoforms, mRNA from these cells was run in
parallel with mRNA from rat jejunum (as a positive control) and probed
with full-length cDNAs corresponding to NHE1 or 3 and an almost
full-length cDNA corresponding to
NHE2. A positive reaction was seen
only with the NHE1 probe in SL-29 cells at high stringency. However,
the size of this transcript was 3.9 kb (Fig.
9) in comparison with the 4.8-kb NHE1 mRNA
of rat jejunum (Fig. 9). Although the NHE2 and NHE3 probes recognized transcripts of
4.4 and
5.2 kb, respectively, in rat enterocytes, they did not recognize any product in SL-29 cells, even under lower
stringency conditions (see Fig. 9 legend). It is unlikely that failure
to detect an NHE2 is due to a partial-length NHE2 probe, because this
probe accounts for all but 24 codons of the 813 codons of NHE2.

View larger version (15K):
[in this window]
[in a new window]
|
Fig. 9.
Northern blotting of SL-29 mRNA with NHE isoform-specific cDNA probes.
A total of 4 µg each of rat jejunal and chicken intestinal
poly(A+) RNA was subjected to
Northern analysis (see MATERIALS AND
METHODS). NHE1 cDNA: prehybridization at 65°C for
2-3 h, followed by overnight hybridization at 50°C. The blots
were washed as follows: 2 × 15 min at 60°C in 2 × SSC
(1× SSC is 0.15 M NaCl and 0.015 M sodium citrate, pH 7.0) and 1 × 30-min at 60°C in 2× SSC + 0.1% SDS. Three
additional washes of 30 min in 2× SSC, the last one with 2% SDS
were included to lower background. Blot was exposed to Kodak XAR film
for 4 days with intensifying screen. Heavy arrow indicates 3.9 kb and
light arrow indicates 4.8 kb. Similar results were obtained with longer
exposures. NHE2 cDNA: prehybridization at 50°C overnight, followed
by hybridization at 50°C for 2 h. Blots were washed as follows:
1 × 15 min at 60°C in 2× SSC and 2 × 30 min at
60°C in 2× SSC, the last one with 2% SDS. Blot was exposed
for 2 days with intensifying screen. Arrow depicts NHE2. Similar
results were obtained with longer exposures. NHE3 cDNA:
prehybridization at 65°C for 2-3 h was followed by overnight
hybridization at 65°C. Washes included 1 × 20 min in 2×
SSC at room temperature and 1 × 15 min in 0.1× SSC + 0.1%
SDS at 65°C. Blot was exposed for 6 days with intensifying screen.
Arrow depicts 5.2-kb NHE3. Similar results were obtained with lower
stringency conditions of washing [2 × 15 min in 2×
SSC and 1 × 30 min in 2× SSC, 0.1% (wt/vol) SDS].
|
|
 |
DISCUSSION |
These studies demonstrate the presence of an
Na+/H+
exchanger in the chicken embryonic fibroblasts SL-29 using
22Na+
uptake measurements. NHE activity, calculated as the
amiloride-sensitive component of total
22Na+
uptake, increased linearly with time (Fig. 1). Our data indicate that
22Na+
uptake in acid-loaded cells is largely due to an
Na+/H+
exchanger and not other
Na+-dependent transporters for
several reasons. First, Na+ uptake
is dependent on H+ extrusion
because there is <22% uptake in the absence of a pH gradient.
Second, uptake was studied in
HCO
3-free conditions, thereby severely
attenuating contributions of
HCO
3-dependent Na+ transport. Furthermore, SITS
did not inhibit transport, suggesting that any metabolically produced
CO2 had no effect on
Na+ uptake. Third, the
Na+-K+-2Cl
cotransport inhibitor furosemide had no significant effect on Na+ uptake (data not shown). The
studies with
22Na+
uptake were corroborated by pHi
measurements using the pH-sensitive fluorescent probe
2',7'-bis(2-carboxyethyl)-5 (and 6)-carboxyfluorescein as
an alternate measure of NHE activity (Bhartur, Chang, and Rao, unpublished observations). The pHi
measurements confirmed the 22Na+
uptake studies on effect of external
Na+ and amiloride (Bhartur, Chang,
and Rao, unpublished observations). However, because determining
pHi is at best an indirect measure of NHE activity, studies on regulation were performed using the more
direct measure of amiloride-sensitive
22Na+
uptake. Exchanger activity responded in a hyperbolic fashion to
increasing extracellular
[Na+] (Fig. 2) and was
not altered by valinomycin. This indicates that the exchanger has a
single external Na+ binding site
and operates in an electroneutral fashion, with a probable
stoichiometry of 1:1. This is similar to the finding in other
vertebrate exchangers (8).
The low IC50 values for inhibition
of SL-29
Na+/H+
exchanger by amiloride and its analogs are more characteristic of NHE1
than NHE2 or 3. A strict comparison of the inhibition
constant values is not possible due to the competitive
nature of Na+ and amiloride
interaction with the exchanger (8, 35). In contrast to the SL-29
exchanger, the chicken intestinal brush-border exchanger, described in
an earlier paper (1, 9), is far less sensitive to inhibition by
amiloride (IC50 28 µM) and its analogs (IC50 DMA 6 µM; EIPA 1.3 µM). This intestinal exchanger resembles mammalian NHE3 in its
amiloride sensitivity and regulation (8, 16, 19, 21, 35).
Regulation of SL-29 NHE exchanger by various agents has some
distinctive features. The stimulation by serum TGF-
, okadaic acid
(Table 1), and hypertonicity (Fig. 7) are features shared with NHE1.
The stimulation by serum and TGF-
suggests the importance of growth
factors in regulating the chicken exchanger and implies a role for
tyrosine kinase pathways. The stimulation with okadaic acid suggests
that basal phosphorylation is important in regulating exchange activity
and that the SL-29 exchanger and/or its modulator protein has a
phosphatase IIA-sensitive site. Interestingly, calyculin A, which
inhibits phosphatase IIA and I with equal efficacy, has a marginal
inhibitory effect on the SL-29 exchanger. We have previously reported
differential effects of these two phosphatase inhibitors for the
Na+-K+-2Cl
cotransporter (29). Complex regulation of the basal phosphorylation state of NHEs involving multiple phosphorylation sites has been suggested (34). The stimulation by hypertonicity makes the SL-29 exchanger similar to NHE1 and NHE2 but distinct from mammalian NHE3,
which is inhibited by cell shrinkage (15). Whether changes in the
cytoskeleton and/or the G protein cascade and/or a
phosphorylation-independent pathway (22) are involved in the effect of
hypertonicity remains to be determined.
In contrast to the above agents, the responses to
Ca2+, the PKC-activator PDB, and
cAMP set the SL-29 exchanger apart from mammalian NHE1. In mammalian
systems, regulation of NHE1 by
Ca2+ is thought to involve
calmodulin (31). Amino acids 636-656 and 657-700 of mammalian
NHE1 are calmodulin binding sites. Increase in intracellular
[Ca2+] results in
binding of calmodulin to the 636-656 region and activates NHE1 by
releasing the autoinhibitory effect of this region. Thus an antibody,
RPI-c28, directed against amino acids 658-815 of NHE1 blocks the
effect of
[Ca2+]-dependent
thrombin in activating NHE1 (34). On the basis of the variable
responses of the SL-29 exchanger to
Ca2+ (Fig. 5), it is tempting to
postulate that the Ca2+-responsive
sites are significantly altered in this molecule. This is substantiated
by the finding that an antibody against amino acids 631-746 failed
to recognize any protein in SL-29 cells (Fig. 8). The protonophore
effects of A-23187 are unlikely to have caused an effect on the
exchange process, because CCCP, another protonophore, was without
effect (data not shown). In marked contrast to its variable effects on
the fibroblast exchanger, Ca2+ is
a predominant inhibitor of the chicken intestinal apical exchanger (20,
27, 28).
The SL-29 exchanger shows a biphasic response to increasing PDB
concentrations (Fig. 4). Maximal stimulation is seen at
10
8 M PDB, a
concentration that correlates well with the affinity of PDB for
purified PKC. This is in contrast to the chicken intestinal apical
exchanger, where 10
8 M PDB
causes maximal inhibition and is monophasic (6). Although a biphasic
response to PDB has been observed with other processes such as chloride
secretion (7), studies in a variety of systems reveal a monophasic
response of NHE1 activity to phorbol esters, making the SL-29 exchanger
unique (reviewed in Refs. 22, 32). Whether the PKC and/or
growth factor stimulation of SL-29 NHE involve a distal common step,
such as the mitogen-activated protein kinase pathway suggested for
mammalian NHE1 regulation (25), remains to be determined.
The cAMP analog cpt-cAMP, which acts via PKA, caused a prominent
dose-dependent inhibition of the SL-29 exchanger (Fig. 6). In mammalian
cells, cAMP has been reported either to stimulate (14) or not have an
effect (16) on NHE1. The trout
-NHE is stimulated by cAMP (21). In
fact,
-NHE, but not NHE1, has PKA consensus sites (21, 26). In
contrast, cAMP consistently inhibits the renal NHE3 (33) and the
chicken intestinal NHE3-like apical exchangers (8, 16, 27, 35). In the
latter case, cAMP is known to act via an elevation in intracellular
[Ca2+] (27) and in the
former appears to involve accessory proteins (reviewed in Ref. 22).
Although the kinetic, pharmacological, and growth factor response data
suggest that the SL-29 NHE is similar to mammalian NHE1, the
immunoblotting, Northern blotting, and
Ca2+ response data suggest that it
is a distinct, albeit related, entity. The SL-29 exchanger is also
distinct from the chicken intestinal brush-border exchanger in terms of
amiloride sensitivity, internal proton binding site, and responses to
Ca2+ and PKC. Furthermore, NHE3
and NHE2 probes fail to recognize a transcript in SL-29 cells. Due to
the high degree of homology between NHE2 and 4 (21, 22, 32, 35), the
results also suggest that SL-29 cells do not have an NHE4-related
transcript. Because a full-length mammalian NHE1 cDNA probe (covering
most of the membrane domain and all of the cytoplasmic domain), but not
an antibody directed against amino acids 631-746 of mammalian NHE1, recognized a product in the SL-29 cells and in chicken
enterocytes (1), the homology may be restricted to the amino-terminal
membranous domain. Recently, Gupta et al. (11) detected a protein in
avian osteoclasts using a monoclonal antibody raised against the entire COOH-terminal domain of porcine NHE1. The recent findings that our
antibody can recognize reptilian forms of NHE1 but fails to recognize
chicken NHE1 reinforces the notion that the chicken NHE is distinct, at
least in one regulatory region, from its better characterized mammalian
counterparts. Similar to our findings in the SL-29 fibroblasts, NHE1
probes reveal a 3.9-kb transcript in chicken osteoclasts (11). An NHE1
homolog is thus present in the chicken and, like mammalian NHE1, is
present in multiple tissues. This NHE1-like protein probably performs
housekeeping functions such as pH regulation and growth.
Phosphorylation is important in SL-29 NHE regulation, but whether it is
the sole regulatory mechanism remains to be determined. Our studies
suggest the existence of an NHE family in aves, which,
although sharing some features with the mammalian NHEs and the trout
-NHE, are distinct entities.
Perspectives
The
Na+/H+
exchangers are a ubiquitous family of proteins, and three recent
reports (1, 9, and the present study) strongly suggest the existence of
an NHE family in aves. The avian family consists of at least an NHE1
homolog (this paper), an NHE2 homolog (9), and an NHE3 homolog (1).
Functional studies indicate that, similar to its mammalian counterpart,
NHE1 is involved in housekeeping functions such as pH regulation and
growth, whereas the NHE2 and NHE3 homologs are involved in vectorial
Na+ transport. However, a striking
feature of this avian family of exchangers is that they are not
uniformly recognized by antibody or cDNA probes of the mammalian
exchangers, suggesting, at the least, that there are interspecies
differences in conformation/sequence of NHEs. In addition, regulation
of the aves NHE1 homolog is distinct from that of its mammalian
counterpart (this paper). Similarly, aves NHE3 homolog shows some
unique features (1, 13, 20, 27, 28). Whether the differences in the
aves' exchangers serve a functional advantage or are a
"harmless" accident of evolution remains to be determined. It is
intriguing to speculate that there must be a special functional
advantage in this diversion, perhaps in its regulation, because the
antibody against mammalian NHE1 can recognize a reptilian NHE (12) but
not the aves form.
 |
ACKNOWLEDGEMENTS |
The authors are indebted to Dr. Jacques Pouyssegur (Centre de
Biochimie, Centre National de la Recherche Scientifique, Nice, France)
for the BamH I NHE1 fragment and the
PS120 and PS127 cells and to Dr. Gary Shull (The University of
Cincinnati, Cincinnati, OH) for the rat NHE1, NHE2, and NHE3 cDNA
fragments. The assistance of Rosemary Clepper in animal care, Linda
Avila-Alaniz in photography, and Janice Gentry and Roli Prasad in word
processing is greatly appreciated.
 |
FOOTNOTES |
Sheela Bhartur was the recipient of a Sigma Xi Foundation Grant-in-Aid
and a Graduate College Fellowship of the University of Illinois at
Chicago. This work was supported by National Institute of Diabetes and
Digestive and Kidney Diseases Grant DK-38510 and the Digestive Disease
Care Research Center of the University of Chicago (DK-42086).
Present address for S. G. Bhartur, Dept. of Medicine, Institute
of Molecular Medicine and Genetics, Medical College of
Georgia, Augusta, GA 30912.
The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement"
in accordance with 18 U.S.C. §1734 solely to indicate this fact.
Address for reprint requests and other correspondence: M. C. Rao, Univ.
of Illinois at Chicago, Dept. of Physiology and Biophysics (M/C 901),
835 South Wolcott Ave., Chicago, IL 60612-7342 (E-mail:
meenarao{at}uic.edu).
Received 10 August 1998; accepted in final form 3 December 1998.
 |
REFERENCES |
1.
Bhartur, S. G.,
C. Bookstein,
M. W. Musch,
R. Boxer,
E. B. Chang,
and
M. C. Rao.
An avian sodium-hydrogen exchanger.
Comp. Biochem. Physiol. A Physiol.
118A:
883-889,
1997[Medline].
2.
Bianchini, L.,
M. Woodside,
C. Sardet,
J. Pouyssegur,
A. Takai,
and
S. Grinstein.
Okadaic acid, a phosphatase inhibitor, induces activation and phosphorylation of the Na+/H+ antiport.
J. Biol. Chem.
266:
15406-15413,
1991[Abstract/Free Full Text].
3.
Bookstein, C.,
A. M. DePaoli,
Y. Xie,
P. Niu,
M. W. Musch,
M. C. Rao,
and
E. B. Chang.
Na+/H+ exchangers, NHE-1 and NHE-3, of rat intestine.
J. Clin. Invest.
93:
106-113,
1994.
4.
Bookstein, C.,
M. W. Musch,
A. DePaoli,
Y. Xie,
M. Villereal,
M. C. Rao,
and
E. B. Chang.
A unique sodium-hydrogen exchange isoform (NHE-4) of the inner medulla of the rat kidney is induced by hyperosmolarity.
J. Biol. Chem.
269:
29704-29709,
1994[Abstract/Free Full Text].
5.
Borgese, F.,
C. Sardet,
M. Cappadoro,
J. Pouyssegur,
and
R. Motais.
Cloning and expression of a cAMP-activated Na+/H+ exchanger: evidence that the cytoplasmic domain mediates hormonal regulation.
Proc. Natl. Acad. Sci. USA
89:
6765-6769,
1992[Abstract/Free Full Text].
6.
Chang, E. B.,
M. W. Musch,
D. Drabik-Arvans,
and
M. C. Rao.
Phorbol ester inhibition of chicken intestinal brush-border sodium-proton exchange.
Am. J. Physiol.
260 (Cell Physiol. 29):
C1264-C1272,
1991[Abstract/Free Full Text].
7.
Chang, E. B.,
and
M. C. Rao.
Intestinal water and electrolyte transport.
In: Physiology of the Gastrointestinal Tract, edited by L. R. Johnson. New York: Raven, 1994, p. 2027-2082.
8.
Counillon, L.,
W. Scholz,
H. J. Lang,
and
J. Pouyssegur.
Pharmacological characterization of stably transfected Na+/H+ antiporter isoforms using amiloride analogs and a new inhibitor exhibiting anti-ischemic properties.
Mol. Pharmacol.
44:
1041-1045,
1993[Abstract].
9.
Donowitz, M.,
C. de la Horra,
M. L. Calonge,
I. S. Wood,
J. Dyer,
S. M. Gribble,
F. Sanchez de Medina,
C. M. Tse,
S. P. Shirazi-Beechey,
and
A. A. Ilundain.
In birds, NHE2 is major brush border Na+/H+ exchanger in colon and is increased by a low-NaCl diet.
Am. J. Physiol.
274 (Regulatory Integrative Comp. Physiol. 43):
R1659-R1669,
1998[Abstract/Free Full Text].
10.
Grinstein, S.,
M. Woodside,
C. Sardet,
J. Pouyssegur,
and
D. Rotin.
Activation of the Na+/H+ antiporter during cell volume regulation. Evidence for a phosphorylation-independent mechanism.
J. Biol. Chem.
267:
23823-23828,
1992[Abstract/Free Full Text].
11.
Gupta, A.,
J. C. Edwards,
and
K. A. Hruska.
Cellular distribution and regulation of NHE-1 isoform of the Na-H exchanger in the avian osteoclast.
Bone
18:
87-95,
1996[Medline].
12.
Harris, S. P.,
T. V. Strong,
N. Wys,
N. W. Richards,
J. Pouyssegur,
S. A. Ernst,
and
D. C. Dawson.
Epithelial localization of a reptilian Na+/H+ exchanger homologous to NHE-1.
Am. J. Physiol.
272 (Gastrointest. Liver Physiol. 35):
G1594-G1606,
1997[Abstract/Free Full Text].
13.
Hirose, R.,
and
E. B. Chang.
Effects of serotonin on Na+/H+ exchange and intracellular calcium in isolated chicken enterocytes.
Am. J. Physiol.
254 (Gastrointest. Liver Physiol. 17):
G891-G897,
1988[Abstract/Free Full Text].
14.
Kandasamy, R. A.,
F. H. Yu,
R. Harris,
A. Boucher,
J. W. Hanrahan,
and
J. Orlowski.
Plasma membrane Na+/H+ exchanger isoforms (NHE-1, -2, and -3) are differentially responsive to second messenger agonists of the protein kinase A and C pathways.
J. Biol. Chem.
270:
29209-29216,
1995[Abstract/Free Full Text].
15.
Kapus, A.,
S. Grinstein,
S. Wasan,
R. Kandasamy,
and
J. Orlowski.
Functional characterization of three isoforms of the Na+/H+ exchanger stably expressed in Chinese hamster ovary cells.
J. Biol. Chem.
269:
23544-23552,
1994[Abstract/Free Full Text].
16.
Levine, S. A.,
M. H. Montrose,
C. M. Tse,
and
M. Donowitz.
Kinetics and regulation of three cloned mammalian Na+/H+ exchangers stably expressed in a fibroblast cell line.
J. Biol. Chem.
268:
25527-25535,
1993[Abstract/Free Full Text].
17.
Li, M.,
P. Morley,
E. K. Asem,
and
B. K. Tsang.
Epidermal growth factor elevates intracellular pH in chicken granulosa cells.
Endocrinology
129:
656-662,
1991[Abstract].
18.
McSwine, R. L.,
G. Babnigg,
M. W. Musch,
E. B. Chang,
and
M. L. Villereal.
Expression and phosphorylation of NHE1 in wild-type and transformed human and rodent fibroblasts.
J. Cell. Physiol.
161:
351-357,
1994[Medline].
19.
Musch, M. W.,
C. Bookstein,
D. L. Arvans,
E. J. Cragoe, Jr.,
M. C. Rao,
and
E. B. Chang.
Characterization of chicken intestinal brush border membrane Na+/H+ exchange.
Comp. Biochem. Physiol. A Physiol.
103A:
439-444,
1992.
20.
Musch, M. W.,
D. Drabik-Arvans,
M. C. Rao,
and
E. B. Chang.
Bethanechol inhibition of chicken intestinal brush border Na+/H+ exchange: role of protein kinase C and other calcium-dependent processes.
J. Cell. Physiol.
152:
362-371,
1992[Medline].
21.
Noel, J.,
and
J. Pouyssegur.
Hormonal regulation, pharmacology, and membrane sorting of vertebrate Na+/H+ exchanger isoforms.
Am. J. Physiol.
268 (Cell Physiol. 37):
C283-C296,
1995[Abstract/Free Full Text].
22.
Orlowski, J.,
and
S. Grinstein.
Na+/H+ exchangers of mammalian cells.
J. Biol. Chem.
272:
22373-22376,
1997[Free Full Text].
23.
Sambrook, J.,
E. F. Fitsch,
and
T. Maniatis.
Molecular Cloning: A Laboratory Manual (2nd ed.). Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1989.
24.
Sardet, C.,
L. Counillon,
A. Franchi,
and
J. Pouyssegur.
Growth factors induce phosphorylation of the Na+/H+ antiporter, a glycoprotein of 110 kD.
Science
247:
723-726,
1990[Abstract/Free Full Text].
25.
Sardet, C.,
P. Fafournoux,
and
J. Pouyssegur.
Alpha-thrombin, epidermal growth factor, and okadaic acid activate the Na+/H+ exchanger, NHE-1, by phosphorylating a set of common sites.
J. Biol. Chem.
266:
19166-19171,
1991[Abstract/Free Full Text].
26.
Sardet, C.,
A. Franchi,
and
J. Pouyssegur.
Molecular cloning, primary structure, and expression of the human growth factor-activatable Na+/H+ antiporter.
Cell
56:
271-280,
1989[Medline].
27.
Semrad, C. E.,
and
E. B. Chang.
Calcium-mediated cyclic AMP inhibition of Na+/H+ exchange in small intestine.
Am. J. Physiol.
252 (Cell Physiol. 21):
C315-C322,
1987[Abstract/Free Full Text].
28.
Semrad, C. E.,
and
E. B. Chang.
Inhibition of Na+/H+ exchange in avian intestine by atrial natriuretic factor.
J. Clin. Invest.
86:
585-591,
1990.
29.
Suvitayavat, W.,
H. C. Palfrey,
M. Haas,
P. B. Dunham,
F. Kalmar,
and
M. C. Rao.
Characterization of the endogenous Na+-K+-2Cl
cotransporter in Xenopus oocytes.
Am. J. Physiol.
266 (Cell Physiol. 35):
C284-C292,
1994[Abstract/Free Full Text].
30.
Toskulkao, C.,
S. Bhartur,
M. W. Musch,
E. B. Chang,
and
M. C. Rao.
Phorbol dibutyrate-specific protein phosphorylation in brush border membranes of chicken enterocytes.
J. Cell. Physiol.
159:
347-355,
1994[Medline].
31.
Wakabayashi, S.,
B. Bertrand,
T. Ikeda,
J. Pouyssegur,
and
M. Shigekawa.
Mutation of calmodulin-binding site renders the Na+/H+ exchanger (NHE1) highly H+-sensitive and Ca2+ regulation-defective.
J. Biol. Chem.
269:
13710-13715,
1994[Abstract/Free Full Text].
32.
Wakabayashi, S.,
M. Shigekawa,
and
J. Pouyssegur.
Molecular physiology of vertebrate Na+/H+ exchangers.
Physiol. Rev.
77:
51-74,
1997[Abstract/Free Full Text].
33.
Weinman, E. J.,
W. P. Dubinsky,
Q. Dinh,
D. Steplock,
and
S. Shenolikar.
Effect of limited trypsin digestion on the renal Na+/H+ exchanger and its regulation by cAMP-dependent protein kinase.
J. Membr. Biol.
109:
233-241,
1989[Medline].
34.
Winkel, G. K.,
C. Sardet,
J. Pouyssegur,
and
H. E. Ives.
Role of cytoplasmic domain of the Na+/H+ exchanger in hormonal activation.
J. Biol. Chem.
268:
3396-3400,
1993[Abstract/Free Full Text].
35.
Yun, C. H. C.,
C.-M. Tse,
S. K. Nath,
S. A. Levine,
S. R. Brant,
and
M. Donowitz.
Mammalian Na+/H+ exchanger gene family: structure and function studies.
Am. J. Physiol.
269 (Gastrointest. Liver Physiol. 32):
G1-G11,
1995[Abstract/Free Full Text].
Am J Physiol Regul Integr Compar Physiol 276(3):R838-R846
0002-9513/99 $5.00
Copyright © 1999 the American Physiological Society